ProQR Therapeutics (PRQR) Shares Outstanding (2012 - 2026)

ProQR Therapeutics (PRQR) has reported Shares Outstanding (Entity) for 15 consecutive years, with $122.6 million the latest figure, recorded in Q1 2026.

• Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $122.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $122.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $119.9 million, up 22.39% from the prior year.
• Shares Outstanding (Entity) advanced to $122.6 million in Q1 2026 per PRQR's latest filing, from $119.9 million in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for PRQR reached as high as $122.6 million in Q1 2025 and fell as low as $85.2 million in Q1 2022.
• A 5-year average of $101.4 million and a median of $95.9 million in 2024 frame the typical range for Shares Outstanding (Entity).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) surged 36.54% — and 2026, when it changed 0.0%.
• Year by year, Shares Outstanding (Entity) stood at $92.0 million in 2022, then advanced by 0.67% to $92.6 million in 2023, then grew by 5.82% to $98.0 million in 2024, then grew by 22.39% to $119.9 million in 2025, then increased by 2.23% to $122.6 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $122.6 million, $119.9 million, and $122.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.